BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21934492)

  • 1. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P; Sun M
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada disease in Thailand.
    Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
    Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease.
    Quek DT; Jap A; Chee SP
    Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
    Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
    Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
    Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Huang X; Zhong H; Chen L; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):736-9. PubMed ID: 12654224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada disease: clinical outcomes.
    Bykhovskaya I; Thorne JE; Kempen JH; Dunn JP; Jabs DA
    Am J Ophthalmol; 2005 Oct; 140(4):674-8. PubMed ID: 16226518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
    Fang W; Zhou H; Yang P; Huang X; Wang L; Kijlstra A
    Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
    Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
    Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic disc swelling in Vogt-Koyanagi-Harada disease.
    Nakao K; Abematsu N; Mizushima Y; Sakamoto T
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1917-22. PubMed ID: 22408010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
    Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
    Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
    AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
    Chee SP; Jap A; Bacsal K
    Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M; Liu Q; Min H; Du H; Hu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
    Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.